Home » Analyst Articles – US

Image for Incyte (NASDAQ:INCY) Receives “Buy” Rating from HC Wainwright

Incyte (NASDAQ:INCY) Receives “Buy” Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Incyte (NASDAQ:INCY – Free Report) in a report released on Wednesday,Benzinga reports. They currently have a $135.00 price objective on the biopharmaceutical company’s... More of this article »
Image for Venture Global (NYSE:VG) Price Target Raised to $14.00 at Wells Fargo & Company

Venture Global (NYSE:VG) Price Target Raised to $14.00 at Wells Fargo & Company

Venture Global (NYSE:VG – Free Report) had its price objective upped by Wells Fargo & Company from $10.00 to $14.00 in a research note published on Wednesday,Benzinga reports. They currently have an equal weight rating on... More of this article »
Image for Venture Global (NYSE:VG) Given New $21.00 Price Target at UBS Group

Venture Global (NYSE:VG) Given New $21.00 Price Target at UBS Group

Venture Global (NYSE:VG – Free Report) had its price objective raised by UBS Group from $19.00 to $21.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other... More of this article »
Image for Braze (NASDAQ:BRZE) Price Target Cut to $28.00 by Analysts at UBS Group

Braze (NASDAQ:BRZE) Price Target Cut to $28.00 by Analysts at UBS Group

Braze (NASDAQ:BRZE – Free Report) had its price objective reduced by UBS Group from $43.00 to $28.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. BRZE... More of this article »
Image for Braze (NASDAQ:BRZE) Price Target Lowered to $35.00 at Stifel Nicolaus

Braze (NASDAQ:BRZE) Price Target Lowered to $35.00 at Stifel Nicolaus

Braze (NASDAQ:BRZE – Free Report) had its target price cut by Stifel Nicolaus from $40.00 to $35.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. Several other research... More of this article »
Image for Braze (NASDAQ:BRZE) Price Target Cut to $40.00 by Analysts at The Goldman Sachs Group

Braze (NASDAQ:BRZE) Price Target Cut to $40.00 by Analysts at The Goldman Sachs Group

Braze (NASDAQ:BRZE – Free Report) had its price target trimmed by The Goldman Sachs Group from $45.00 to $40.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a buy rating on... More of this article »
Image for HC Wainwright Issues Positive Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

HC Wainwright Issues Positive Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price objective upped by HC Wainwright from $110.00 to $120.00 in a research report report published on Wednesday,Benzinga reports. They currently have a buy rating on... More of this article »
Image for TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler

TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler

TELA Bio (NASDAQ:TELA – Free Report) had its target price cut by Piper Sandler from $1.25 to $1.00 in a research note released on Wednesday,Benzinga reports. They currently have a neutral rating on the stock. Several other equities... More of this article »
Image for Super Micro Computer (NASDAQ:SMCI) Price Target Lowered to $32.00 at Rosenblatt Securities

Super Micro Computer (NASDAQ:SMCI) Price Target Lowered to $32.00 at Rosenblatt Securities

Super Micro Computer (NASDAQ:SMCI – Free Report) had its price objective trimmed by Rosenblatt Securities from $50.00 to $32.00 in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has a buy... More of this article »
Image for ARM (NASDAQ:ARM) Price Target Raised to $140.00 at Deutsche Bank Aktiengesellschaft

ARM (NASDAQ:ARM) Price Target Raised to $140.00 at Deutsche Bank Aktiengesellschaft

ARM (NASDAQ:ARM – Free Report) had its price objective upped by Deutsche Bank Aktiengesellschaft from $125.00 to $140.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have a hold... More of this article »
Image for Core & Main (NYSE:CNM) Given New $62.00 Price Target at Barclays

Core & Main (NYSE:CNM) Given New $62.00 Price Target at Barclays

Core & Main (NYSE:CNM – Free Report) had its target price trimmed by Barclays from $63.00 to $62.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the... More of this article »
Image for Hexcel (NYSE:HXL) Coverage Initiated by Analysts at KeyCorp

Hexcel (NYSE:HXL) Coverage Initiated by Analysts at KeyCorp

KeyCorp assumed coverage on shares of Hexcel (NYSE:HXL – Free Report) in a report published on Wednesday. The firm issued a sector weight rating on the aerospace company’s stock. A number of other research analysts have... More of this article »
Image for ARM (NASDAQ:ARM) Given New $165.00 Price Target at Wells Fargo & Company

ARM (NASDAQ:ARM) Given New $165.00 Price Target at Wells Fargo & Company

ARM (NASDAQ:ARM – Free Report) had its price target increased by Wells Fargo & Company from $150.00 to $165.00 in a research note published on Wednesday,Benzinga reports. The brokerage currently has an overweight rating... More of this article »
Image for General Motors (NYSE:GM) Rating Increased to Outperform at Wolfe Research

General Motors (NYSE:GM) Rating Increased to Outperform at Wolfe Research

Wolfe Research upgraded shares of General Motors (NYSE:GM – Free Report) (TSE:GMM.U) from a peer perform rating to an outperform rating in a report issued on Wednesday morning, MarketBeat.com reports. They currently have $96.00... More of this article »
Image for Cleveland-Cliffs (NYSE:CLF) Now Covered by KeyCorp

Cleveland-Cliffs (NYSE:CLF) Now Covered by KeyCorp

KeyCorp started coverage on shares of Cleveland-Cliffs (NYSE:CLF – Free Report) in a report released on Wednesday. The firm issued a sector weight rating on the mining company’s stock. Other equities analysts have also... More of this article »
Image for Karyopharm Therapeutics (NASDAQ:KPTI) Given New $8.00 Price Target at HC Wainwright

Karyopharm Therapeutics (NASDAQ:KPTI) Given New $8.00 Price Target at HC Wainwright

Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) had its price objective reduced by HC Wainwright from $15.00 to $8.00 in a report released on Wednesday,Benzinga reports. They currently have a buy rating on the stock. Other... More of this article »
Image for Immix Biopharma (NASDAQ:IMMX) Now Covered by Morgan Stanley

Immix Biopharma (NASDAQ:IMMX) Now Covered by Morgan Stanley

Morgan Stanley initiated coverage on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a research report released on Wednesday morning, MarketBeat reports. The brokerage issued an overweight rating and a $20.00 price objective... More of this article »
Image for Concentrix (NASDAQ:CNXC) Price Target Lowered to $55.00 at Canaccord Genuity Group

Concentrix (NASDAQ:CNXC) Price Target Lowered to $55.00 at Canaccord Genuity Group

Concentrix (NASDAQ:CNXC – Free Report) had its target price lowered by Canaccord Genuity Group from $80.00 to $55.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage currently has a... More of this article »
Image for HC Wainwright Issues Positive Forecast for Bitcoin Depot (NASDAQ:BTM) Stock Price

HC Wainwright Issues Positive Forecast for Bitcoin Depot (NASDAQ:BTM) Stock Price

Bitcoin Depot (NASDAQ:BTM – Free Report) had its price target boosted by HC Wainwright from $3.50 to $4.00 in a report issued on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. A number... More of this article »
Image for Comcast (NASDAQ:CMCSA) Price Target Cut to $28.00 by Analysts at The Goldman Sachs Group

Comcast (NASDAQ:CMCSA) Price Target Cut to $28.00 by Analysts at The Goldman Sachs Group

Comcast (NASDAQ:CMCSA – Free Report) had its price target cut by The Goldman Sachs Group from $30.00 to $28.00 in a research report sent to investors on Wednesday,MarketScreener reports. They currently have a neutral rating on... More of this article »
Image for EVgo’s (EVGO) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

EVgo’s (EVGO) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their neutral rating on shares of EVgo (NASDAQ:EVGO – Free Report) in a research report report published on Wednesday, MarketBeat reports. Several other analysts also recently issued reports... More of this article »
Image for Kestra Medical Technologies’ (KMTS) “Buy” Rating Reaffirmed at BTIG Research

Kestra Medical Technologies’ (KMTS) “Buy” Rating Reaffirmed at BTIG Research

BTIG Research reiterated their buy rating on shares of Kestra Medical Technologies (NASDAQ:KMTS – Free Report) in a report issued on Wednesday,Benzinga reports. BTIG Research currently has a $32.00 price objective on the stock. A... More of this article »
Image for Draganfly (NASDAQ:DPRO) Price Target Cut to $12.00 by Analysts at Needham & Company LLC

Draganfly (NASDAQ:DPRO) Price Target Cut to $12.00 by Analysts at Needham & Company LLC

Draganfly (NASDAQ:DPRO – Free Report) had its target price decreased by Needham & Company LLC from $14.00 to $12.00 in a report published on Wednesday morning, Marketbeat Ratings reports. Needham & Company LLC currently... More of this article »
Image for Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Now Covered by Analysts at Evercore

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Now Covered by Analysts at Evercore

Evercore began coverage on shares of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA – Free Report) in a report issued on Wednesday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $46.00 price... More of this article »
Image for DocGo (NASDAQ:DCGO) Price Target Cut to $1.00 by Analysts at Canaccord Genuity Group

DocGo (NASDAQ:DCGO) Price Target Cut to $1.00 by Analysts at Canaccord Genuity Group

DocGo (NASDAQ:DCGO – Free Report) had its target price cut by Canaccord Genuity Group from $1.50 to $1.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have a hold rating on the stock. Several... More of this article »
Image for Concentrix (NASDAQ:CNXC) Given New $40.00 Price Target at Robert W. Baird

Concentrix (NASDAQ:CNXC) Given New $40.00 Price Target at Robert W. Baird

Concentrix (NASDAQ:CNXC – Free Report) had its price target trimmed by Robert W. Baird from $52.00 to $40.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Other... More of this article »
Image for HC Wainwright Issues Positive Forecast for Jade Biosciences (NASDAQ:JBIO) Stock Price

HC Wainwright Issues Positive Forecast for Jade Biosciences (NASDAQ:JBIO) Stock Price

Jade Biosciences (NASDAQ:JBIO – Free Report) had its target price upped by HC Wainwright from $25.00 to $35.00 in a research note released on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the... More of this article »
Image for Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Cut to $15.00 by Analysts at Robert W. Baird

Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Cut to $15.00 by Analysts at Robert W. Baird

Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) had its price target trimmed by Robert W. Baird from $21.00 to $15.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on... More of this article »
Image for Leonardo DRS (NASDAQ:DRS) Price Target Raised to $55.00 at Bank of America

Leonardo DRS (NASDAQ:DRS) Price Target Raised to $55.00 at Bank of America

Leonardo DRS (NASDAQ:DRS – Free Report) had its target price upped by Bank of America from $50.00 to $55.00 in a research note released on Wednesday morning,Benzinga reports. Bank of America currently has a buy rating on the... More of this article »
Image for Bicara Therapeutics (NASDAQ:BCAX) Coverage Initiated by Analysts at Bank of America

Bicara Therapeutics (NASDAQ:BCAX) Coverage Initiated by Analysts at Bank of America

Bank of America started coverage on shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) in a report released on Wednesday, MarketBeat reports. The brokerage issued a buy rating and a $35.00 price target on the stock. Several... More of this article »
Image for BioNTech (NASDAQ:BNTX) Receives Buy Rating from Jefferies Financial Group

BioNTech (NASDAQ:BNTX) Receives Buy Rating from Jefferies Financial Group

Jefferies Financial Group restated their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report published on Wednesday morning,MarketScreener reports. Several other equities analysts have also recently issued... More of this article »
Image for Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.50 at Barclays

Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.50 at Barclays

Aveanna Healthcare (NASDAQ:AVAH – Free Report) had its price target reduced by Barclays from $11.00 to $9.50 in a research report report published on Wednesday,Benzinga reports. They currently have an overweight rating on the... More of this article »
Image for Avalo Therapeutics (NASDAQ:AVTX) Price Target Raised to $40.00 at HC Wainwright

Avalo Therapeutics (NASDAQ:AVTX) Price Target Raised to $40.00 at HC Wainwright

Avalo Therapeutics (NASDAQ:AVTX – Free Report) had its price objective upped by HC Wainwright from $25.00 to $40.00 in a research report report published on Wednesday,Benzinga reports. HC Wainwright currently has a buy rating... More of this article »
Image for Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $245.00 at Guggenheim

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $245.00 at Guggenheim

Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price objective raised by Guggenheim from $220.00 to $245.00 in a research note published on Wednesday,Benzinga reports. Guggenheim currently has a buy rating on the stock. AXSM... More of this article »
Image for KB Home (NYSE:KBH) Price Target Lowered to $54.00 at Truist Financial

KB Home (NYSE:KBH) Price Target Lowered to $54.00 at Truist Financial

KB Home (NYSE:KBH – Free Report) had its price target reduced by Truist Financial from $65.00 to $54.00 in a report published on Wednesday,Benzinga reports. They currently have a hold rating on the construction company’s... More of this article »
Image for KB Home (NYSE:KBH) Given New $50.00 Price Target at Wells Fargo & Company

KB Home (NYSE:KBH) Given New $50.00 Price Target at Wells Fargo & Company

KB Home (NYSE:KBH – Free Report) had its price target cut by Wells Fargo & Company from $55.00 to $50.00 in a research note published on Wednesday,Benzinga reports. They currently have an underweight rating on the construction... More of this article »
Image for Pilgrim’s Pride (NASDAQ:PPC) Price Target Lowered to $40.00 at BMO Capital Markets

Pilgrim’s Pride (NASDAQ:PPC) Price Target Lowered to $40.00 at BMO Capital Markets

Pilgrim’s Pride (NASDAQ:PPC – Free Report) had its target price lowered by BMO Capital Markets from $42.00 to $40.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has a market perform... More of this article »
Image for Microsoft (NASDAQ:MSFT) Price Target Cut to $510.00 by Analysts at UBS Group

Microsoft (NASDAQ:MSFT) Price Target Cut to $510.00 by Analysts at UBS Group

Microsoft (NASDAQ:MSFT – Free Report) had its price objective trimmed by UBS Group from $600.00 to $510.00 in a research report report published on Wednesday, Marketbeat.com reports. The brokerage currently has a buy rating on... More of this article »
Image for Progress Software (NASDAQ:PRGS) Price Target Lowered to $50.00 at DA Davidson

Progress Software (NASDAQ:PRGS) Price Target Lowered to $50.00 at DA Davidson

Progress Software (NASDAQ:PRGS – Free Report) had its price objective lowered by DA Davidson from $70.00 to $50.00 in a report issued on Wednesday morning,Benzinga reports. DA Davidson currently has a buy rating on the software... More of this article »
Image for BMO Capital Markets Issues Positive Forecast for Halliburton (NYSE:HAL) Stock Price

BMO Capital Markets Issues Positive Forecast for Halliburton (NYSE:HAL) Stock Price

Halliburton (NYSE:HAL – Free Report) had its target price increased by BMO Capital Markets from $39.00 to $42.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a market perform... More of this article »
Image for Four Corners Property Trust (NYSE:FCPT) Upgraded by Citizens Jmp to “Outperform” Rating

Four Corners Property Trust (NYSE:FCPT) Upgraded by Citizens Jmp to “Outperform” Rating

Citizens Jmp upgraded shares of Four Corners Property Trust (NYSE:FCPT – Free Report) from a market perform rating to an outperform rating in a research report released on Wednesday morning, MarketBeat.com reports. The brokerage... More of this article »
Image for Amazon.com (NASDAQ:AMZN) Price Target Raised to $285.00 at Citigroup

Amazon.com (NASDAQ:AMZN) Price Target Raised to $285.00 at Citigroup

Amazon.com (NASDAQ:AMZN) had its price target boosted by Citigroup from $265.00 to $285.00 in a report published on Wednesday morning, Marketbeat.com reports. They currently have a buy rating on the e-commerce giant’s stock. Several... More of this article »
Image for Jefferies Financial Group Issues Positive Forecast for Kingsoft Cloud (NASDAQ:KC) Stock Price

Jefferies Financial Group Issues Positive Forecast for Kingsoft Cloud (NASDAQ:KC) Stock Price

Kingsoft Cloud (NASDAQ:KC – Free Report) had its price target lifted by Jefferies Financial Group from $17.00 to $19.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have a buy rating on... More of this article »
Image for Bank of America Issues Positive Forecast for BWX Technologies (NYSE:BWXT) Stock Price

Bank of America Issues Positive Forecast for BWX Technologies (NYSE:BWXT) Stock Price

BWX Technologies (NYSE:BWXT – Free Report) had its price objective hoisted by Bank of America from $230.00 to $250.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Image for Composecure’s (GPGI) “Buy” Rating Reaffirmed at Needham & Company LLC

Composecure’s (GPGI) “Buy” Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Composecure (NYSE:GPGI – Free Report) in a research report report published on Wednesday,Benzinga reports. Separately, Weiss Ratings began coverage on Composecure... More of this article »
Image for Absci (NASDAQ:ABSI) Receives “Buy” Rating from Needham & Company LLC

Absci (NASDAQ:ABSI) Receives “Buy” Rating from Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Absci (NASDAQ:ABSI – Free Report) in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a $7.00 price objective on... More of this article »
Image for ESCO Technologies (NYSE:ESE) Now Covered by Analysts at Deutsche Bank Aktiengesellschaft

ESCO Technologies (NYSE:ESE) Now Covered by Analysts at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft initiated coverage on shares of ESCO Technologies (NYSE:ESE – Free Report) in a research report report published on Wednesday, MarketBeat Ratings reports. The brokerage issued a buy rating and... More of this article »
Image for ATI (NYSE:ATI) Now Covered by KeyCorp

ATI (NYSE:ATI) Now Covered by KeyCorp

KeyCorp assumed coverage on shares of ATI (NYSE:ATI – Free Report) in a report issued on Wednesday. The brokerage issued an overweight rating and a $140.00 price target on the basic materials company’s stock. ATI has been... More of this article »
Image for Commercial Metals (NYSE:CMC) Now Covered by KeyCorp

Commercial Metals (NYSE:CMC) Now Covered by KeyCorp

KeyCorp assumed coverage on shares of Commercial Metals (NYSE:CMC – Free Report) in a report published on Wednesday. The firm issued a sector weight rating on the basic materials company’s stock. A number of other research... More of this article »
Image for ACADIA Pharmaceuticals (NASDAQ:ACAD) Upgraded to Buy at Bank of America

ACADIA Pharmaceuticals (NASDAQ:ACAD) Upgraded to Buy at Bank of America

Bank of America upgraded shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) from a neutral rating to a buy rating in a report published on Wednesday morning, MarketBeat.com reports. They currently have $29.00 price... More of this article »